JY
TAK icon

Jeff Yass’s Takeda Pharmaceutical TAK Stock Holding History

Jeff Yass’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Sell
13,899
-27,525
-66% -$455K ﹤0.01% 11710
2026
Q1 		$767K Buy
41,424
+12,749
+44% +$224K ﹤0.01% 8581
2025
Q4 		$447K Buy
+28,675
New +$410K ﹤0.01% 9062
2025
Q3 		– Sell
-10,810
Closed -$161K – 13839
2025
Q2 		$167K Sell
10,810
-36,219
-77% -$535K ﹤0.01% 11388
2025
Q1 		$699K Buy
47,029
+21,118
+82% +$296K ﹤0.01% 8143
2024
Q4 		$343K Buy
25,911
+11,619
+81% +$160K ﹤0.01% 9540
2024
Q3 		$203K Buy
+14,292
New +$203K ﹤0.01% 10441
2024
Q2 		– Sell
-10,569
Closed -$147K – 13213
2024
Q1 		$147K Sell
10,569
-28,069
-73% -$408K ﹤0.01% 10920
2023
Q4 		$551K Buy
38,638
+27,323
+241% +$388K ﹤0.01% 8416
2023
Q3 		$175K Buy
+11,315
New +$175K ﹤0.01% 10374
2023
Q2 		– Sell
-11,668
Closed -$191K – 13113
2023
Q1 		$192K Sell
11,668
-84,551
-88% -$1.35M ﹤0.01% 10645
2022
Q4 		$1.5M Buy
96,219
+65,994
+218% +$922K ﹤0.01% 5283
2022
Q3 		$392K Sell
30,225
-152,117
-83% -$2.12M ﹤0.01% 9109
2022
Q2 		$2.56M Sell
182,342
-87,478
-32% -$1.25M ﹤0.01% 4379
2022
Q1 		$3.86M Sell
269,820
-283,045
-51% -$4.16M ﹤0.01% 4140
2021
Q4 		$7.54M Sell
552,865
-559,943
-50% -$7.85M ﹤0.01% 3100
2021
Q3 		$18.2M Sell
1,112,808
-17,950
-2% -$301K ﹤0.01% 2073
2021
Q2 		$19M Sell
1,130,758
-408,827
-27% -$6.96M ﹤0.01% 2091
2021
Q1 		$28.1M Buy
1,539,585
+523,298
+51% +$9.42M ﹤0.01% 1526
2020
Q4 		$18.5M Buy
1,016,287
+553,550
+120% +$9.71M ﹤0.01% 1830
2020
Q3 		$8.26M Buy
462,737
+64,450
+16% +$1.17M ﹤0.01% 2419
2020
Q2 		$7.14M Sell
398,287
-239,967
-38% -$4.31M ﹤0.01% 2550
2020
Q1 		$9.69M Buy
638,254
+483,226
+312% +$8.76M ﹤0.01% 1770
2019
Q4 		$3.06M Sell
155,028
-55,110
-26% -$1.05M ﹤0.01% 3663
2019
Q3 		$3.61M Buy
210,138
+88,327
+73% +$1.53M ﹤0.01% 3199
2019
Q2 		$2.16M Buy
+121,811
New +$2.22M ﹤0.01% 4032

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Jeff Yass's TAK Position: Q2 2026 in Review

Jeff Yass reduced its Takeda Pharmaceutical (TAK) stake by 66% in Q2 2026, selling an estimated $455K and leaving 13,899 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #11710.

Jeff Yass first reported a position in TAK in Q2 2019 and has held it in 26 quarters since. The position peaked at $28.1M in Q1 2021. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Jeff Yass held 13,899 shares of Takeda Pharmaceutical worth $223K as of Q2 2026.
  • Jeff Yass sold 27,525 Takeda Pharmaceutical shares in Q2 2026, an estimated $455K.
  • Takeda Pharmaceutical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11710 holding.
  • Jeff Yass first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 26 quarters since.
  • Jeff Yass's Takeda Pharmaceutical position peaked at $28.1M in Q1 2021.
  • 375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.